Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomea Fusion, Inc. (BMEA)  
$0.96 0.05 (5.22%) as of 4:30 Tue 12/2


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 59,510,000
Market Cap: 56.97(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.982 - $7.27
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Biomea Fusion is a biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. Co.'s proprietary FUSION System discovery platform is built to advance a pipeline of novel irreversible small molecule product candidates. Co.'s lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 22,509
Total Buy Value $0 $0 $0 $155,961
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 2
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2025-09-04 2025-06-03 2024-12-03 2023-12-04

   
Records found: 50
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Erdtmann Rainer M See Remarks   •       •      –    2025-12-01 4 B $1.05 $10,500 D/D 10,000 693,027 0.01     -
   Erdtmann Rainer M See Remarks   •       •      –    2025-11-28 4 B $1.10 $44,052 D/D 40,000 683,027 0.01     -
   Erdtmann Rainer M See Remarks   •       •      –    2025-01-31 4 GA $0.00 $0 I/I 30,000 20,000     -
   Erdtmann Rainer M See Remarks   •       •      –    2025-01-31 4 GD $0.00 $0 D/D 30,000 643,027     -
   Erdtmann Rainer M See Remarks   •       •      –    2025-01-28 4 GD $0.00 $0 D/D 40,000 673,027     -
   Valle Franco Chief Financial Officer   •       –      –    2024-11-30 4 A $6.15 $3,046 D/D 495 42,995     -
   Hitchcock Michael J.m.   –       •      –    2024-09-30 4 B $10.06 $100,600 D/D 10,000 15,000 0.01 -63%     
   Valle Franco Chief Financial Officer   •       –      –    2024-06-11 4 B $4.43 $55,361 D/D 12,509 42,500 0.01 154%     
   Valle Franco Chief Financial Officer   •       –      –    2024-05-31 4 A $3.78 $16,825 D/D 4,448 29,991     -
   Frias Juan Pablo Chief Medical Officer   •       –      –    2024-05-31 4 A $8.94 $3,121 D/D 349 349     -
   Erdtmann Rainer M President and COO   •       •      –    2023-12-29 4 GD $0.00 $0 D/D 21,000 713,027     -
   Erdtmann Rainer M President and COO   •       •      –    2023-12-29 4 GA $0.00 $0 I/I 9,000 10,000     -
   Valle Franco Chief Financial Officer   •       –      –    2023-11-30 4 A $3.78 $5,087 D/D 1,345 25,543     -
   A2a Pharmaceuticals, Inc. 10% Owner   –       –       •   2023-06-01 4 S $34.56 $1,728,165 D/D (50,000) 3,500,000 66%     
   A2a Pharmaceuticals, Inc. 10% Owner   –       –       •   2023-05-31 4 S $33.81 $2,535,750 D/D (75,000) 3,550,000 63%     
   Valle Franco Chief Financial Officer   •       –      –    2023-05-31 4 A $3.78 $16,163 D/D 4,273 24,198     -
   A2a Pharmaceuticals, Inc. 10% Owner   –       –       •   2023-05-12 4 S $33.84 $846,000 D/D (25,000) 3,625,000 59%     
   A2a Pharmaceuticals, Inc. 10% Owner   –       –       •   2023-05-09 4 S $34.50 $5,175,720 D/D (150,000) 3,650,000 55%     
   A2a Pharmaceuticals, Inc. 10% Owner   –       –       •   2023-05-08 4 S $33.99 $3,399,310 D/D (100,000) 3,800,000 55%     
   A2a Pharmaceuticals, Inc. 10% Owner   –       –       •   2023-04-20 4 S $29.12 $5,823,760 D/D (200,000) 3,900,000 45%     
   A2a Pharmaceuticals, Inc. 10% Owner   –       –       •   2023-03-31 4 S $31.25 $6,250,000 D/D (200,000) 4,100,000 40%     
   A2a Pharmaceuticals, Inc. 10% Owner   –       –       •   2023-03-31 4/A S $31.25 $6,250,000 D/D (200,000) 4,100,000     -
   Valle Franco Chief Financial Officer   •       –      –    2022-11-30 4 A $3.78 $9,524 D/D 2,518 19,925     -
   Hitchcock Michael J.m. Director   –       •      –    2022-11-14 4 B $7.93 $39,650 D/D 5,000 5,000 2.39 285%     
   Valle Franco Chief Financial Officer   •       –      –    2022-11-11 4 B $7.63 $31,286 D/D 4,100 17,407 2.74 95%     
  50 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us